These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 3129815

  • 1. Autoradiographic and immunoblotting analyses of the activation pathways of plasminogen by urokinase and tissue plasminogen activator in the plasma or clotted plasma.
    Takada A, Yoshida M, Takada Y.
    Thromb Res; 1988 Jan 15; 49(2):193-204. PubMed ID: 3129815
    [Abstract] [Full Text] [Related]

  • 2. Differences in the activation rates of plasminogen by tissue plasminogen activator and urokinase.
    Takada A, Shizume K, Cho M, Takada Y.
    Thromb Res; 1987 Feb 15; 45(4):371-81. PubMed ID: 2437668
    [Abstract] [Full Text] [Related]

  • 3. Effects of fibrin on the enhanced activation of plasminogen by urokinase and tissue plasminogen activator: role of cross-link.
    Takada A, Watahiki Y, Takada Y.
    Thromb Res; 1986 Mar 01; 41(5):605-13. PubMed ID: 3083529
    [Abstract] [Full Text] [Related]

  • 4. Activation of Val442-plasminogen (mini-plasminogen) by urokinase, streptokinase and tissue plasminogen activator.
    Takada A, Takada Y, Sugawara Y.
    Thromb Res; 1988 Jan 15; 49(2):253-63. PubMed ID: 3129817
    [Abstract] [Full Text] [Related]

  • 5. Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.
    Thorsen S, Müllertz S, Suenson E, Kok P.
    Biochem J; 1984 Oct 01; 223(1):179-87. PubMed ID: 6208894
    [Abstract] [Full Text] [Related]

  • 6. Activation pathway of glu-plasminogen to Lys-plasmin by urokinase.
    Takada A, Takada Y.
    Thromb Res; 1982 Sep 15; 27(6):671-7. PubMed ID: 6129717
    [Abstract] [Full Text] [Related]

  • 7. Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.
    Pannell R, Black J, Gurewich V.
    J Clin Invest; 1988 Mar 15; 81(3):853-9. PubMed ID: 2963831
    [Abstract] [Full Text] [Related]

  • 8. Physiology of plasminogen: with special reference to activation and degradation.
    Takada A, Takada Y.
    Haemostasis; 1988 Mar 15; 18 Suppl 1():25-35. PubMed ID: 3280423
    [Abstract] [Full Text] [Related]

  • 9. Potentiation by Lys-plasminogen of clot lysis by single or two chain urokinase-type plasminogen activator or tissue-type plasminogen activator.
    Watahiki Y, Scully MF, Ellis V, Kakkar VV.
    Thromb Haemost; 1989 Jun 30; 61(3):502-6. PubMed ID: 2508259
    [Abstract] [Full Text] [Related]

  • 10. A comparative study of the efficacy and specificity of tissue plasminogen activator and pro-urokinase: demonstration of synergism and of different thresholds of non-selectivity.
    Gurewich V, Pannell R.
    Thromb Res; 1986 Oct 15; 44(2):217-28. PubMed ID: 3097872
    [Abstract] [Full Text] [Related]

  • 11. The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin.
    Rouy D, Anglés-Cano E.
    Biochem J; 1990 Oct 01; 271(1):51-7. PubMed ID: 1699517
    [Abstract] [Full Text] [Related]

  • 12. Effects of fibrinogen and fibrin on the activation of Glu- and Lys-plasminogen by urokinase.
    Takada A, Takada Y, Sugawara Y.
    Thromb Res; 1984 Mar 15; 33(6):561-9. PubMed ID: 6539003
    [Abstract] [Full Text] [Related]

  • 13. Activation of fibrin-bound plasminogen by pro-urokinase and its complementariness with that by tissue plasminogen activator.
    Gurewich V.
    Enzyme; 1988 Mar 15; 40(2-3):97-108. PubMed ID: 2971533
    [Abstract] [Full Text] [Related]

  • 14. Differences between neonates and adults in the urokinase-plasminogen activator (u-PA) pathway of the fibrinolytic system.
    Ries M, Zenker M, Gaffney PJ.
    Thromb Res; 2000 Nov 15; 100(4):341-51. PubMed ID: 11113278
    [Abstract] [Full Text] [Related]

  • 15. Identification of molecular forms of plasminogen and plasmin-inhibitor complexes in urokinase-activated human plasma.
    Müllertz S, Thorsen S, Sottrup-Jensen L.
    Biochem J; 1984 Oct 01; 223(1):169-77. PubMed ID: 6208893
    [Abstract] [Full Text] [Related]

  • 16. Effects of heparan sulfate analogue or other sulfated polysaccharides on the activation of plasminogen by t-PA or u-PA.
    Takada Y, Urano T, Takada A.
    Thromb Res; 1994 Mar 01; 73(5):301-11. PubMed ID: 8016815
    [Abstract] [Full Text] [Related]

  • 17. Tissue plasminogen activator and urokinase mediate the binding of Glu-plasminogen to plasma fibrin I. Evidence for new binding sites in plasmin-degraded fibrin I.
    Harpel PC, Chang TS, Verderber E.
    J Biol Chem; 1985 Apr 10; 260(7):4432-40. PubMed ID: 3156857
    [Abstract] [Full Text] [Related]

  • 18. Mechanism of the synergistic effect between oversulfated chondroitin-6-sulfate and lysine or 6-aminohexanoic acid in enhancing the in-vitro activation of glutamic plasminogen by tissue plasminogen activator or urokinase.
    Kouemo S, McMillan E, Doctor V.
    Blood Coagul Fibrinolysis; 2010 Jul 10; 21(5):425-30. PubMed ID: 20445443
    [Abstract] [Full Text] [Related]

  • 19. Mechanism of the stimulatory effect of 6-aminohexanoic acid on plasminogen activation by streptokinase or tissue plasminogen activator: the role of chloride.
    Guinn L, Doctor VM.
    Eur J Drug Metab Pharmacokinet; 2003 Jul 10; 28(4):315-20. PubMed ID: 14743974
    [Abstract] [Full Text] [Related]

  • 20. The activation of two isozymes of glu-plasminogen (I and II) by urokinase and streptokinase.
    Takada A, Takada Y.
    Thromb Res; 1983 Jun 15; 30(6):633-42. PubMed ID: 6351345
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.